6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin-Reference-Cited by-同舟云学术

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

Published:2015-03 Issue:8 Volume:65 Page:777-786
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Gilard Martine,Barragan Paul,Noryani Arif A.L.,Noor Hussam A.,Majwal Talib,Hovasse Thomas,Castellant Philippe,Schneeberger Michel,Maillard Luc,Bressolette Erwan,Wojcik Jaroslaw,Delarche Nicolas,Blanchard Didier,Jouve Bernard,Ormezzano Olivier,Paganelli Franck,Levy Gilles,Sainsous Joël,Carrie Didier,Furber Alain,Berland Jacques,Darremont Oliver,Le Breton Hervé,Lyuycx-Bore Anne,Gommeaux Antoine,Cassat Claude,Kermarrec Alain,Cazaux Pierre,Druelles Philippe,Dauphin Raphael,Armengaud Jean,Dupouy Patrick,Champagnac Didier,Ohlmann Patrick,Endresen Knut,Benamer Hakim,Kiss Robert Gabor,Ungi Imre,Boschat Jacques,Morice Marie-Claude

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

2. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

3. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis;Stettler;Lancet,2007

4. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials;Bangalore;Circulation,2012

5. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction;Kalesan;Eur Heart J,2012

Cited by 331 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy in Patients with Chronic Coronary Syndromes;Interventional Cardiology Clinics;2024-10

2. P2Y12 Receptor Inhibitor for Antiaggregant Therapies: From Molecular Pathway to Clinical Application;International Journal of Molecular Sciences;2024-07-10

3. Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention;JAMA Network Open;2024-03-28

4. Antiplatelet Treatment Preferences of a Group of Cardiologists from Türkiye: A Survey Research Study;Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology;2024

5. Efficacy and Safety of Long-Term Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis;Clinical and Applied Thrombosis/Hemostasis;2024-01